Using alteplase to clear occlusions.
Moureau
Nancy
N
PICC Excellence, Inc., Orange Park, Fla., USA.
D002405:Catheterization, Central Venous / Q000009:adverse effects*; D002408:Catheters, Indwelling / Q000009:adverse effects*; D004868:Equipment Failure; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007507:Therapeutic Irrigation / Q000379:methods; D013927:Thrombosis / Q000188:drug therapy* / Q000209:etiology; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator